Drugs with this side effect as MedDRA Preferred Term
- Enfuvirtide
- Disturbance in attention: 1.9% - 2.3%
- Insulin
- K779
- Cerebration impaired: 1% - 21%
- MDV3100
- NovoLog
- Sativex
- acetaminophen
- Disturbance in attention: common
- almotriptan
- Cerebration impaired: rare
- alprazolam
- Disturbance in attention: 3.2%
- Cerebration impaired
- amantadine
- Cerebration impaired: common
- amitriptyline
- amoxapine
- amphetamine
- aripiprazole
- Disturbance in attention: 1% - 3%
- Cerebration impaired
- betaxolol
- boceprevir
- Disturbance in attention: common
- bortezomib
- bosentan
- buprenorphine
- Disturbance in attention
- Cerebration impaired
- bupropion
- Disturbance in attention
- Cerebration impaired: 3% - 9%
- Impairment of attention: rare
- cabergoline
- cabozantinib
- carvedilol
- cefpodoxime
- cetirizine
- chlorpheniramine
- ciprofloxacin
- citalopram
- Cerebration impaired: uncommon, frequent
- Disturbance in attention: infrequent
- clomipramine
- Disturbance in attention
- Cerebration impaired: common, 5%
- clonazepam
- cyclobenzaprine
- Disturbance in attention: 6%
- Cerebration impaired
- darunavir
- delavirdine
- desmopressin
- desvenlafaxine
- Disturbance in attention: 1% - 2%
- diazepam
- diclofenac
- dihydroergotamine
- Cerebration impaired: infrequent
- dothiepin
- doxazosin
- doxepin
- Disturbance in attention: rare
- Cerebration impaired
- duloxetine
- Disturbance in attention: postmarketing, infrequent, uncommon
- efavirenz
- Disturbance in attention: common, 3.6%
- Cerebration impaired: 0% - 9%
- entacapone
- eslicarbazepine acetate
- ethosuximide
- etravirine
- felbamate
- fentanyl
- Disturbance in attention
- Cerebration impaired
- fluoxetine
- Disturbance in attention
- Cerebration impaired
- frovatriptan
- Cerebration impaired: infrequent
- furosemide
- gliclazide
- Poor concentration
- Cerebration impaired
- glimepiride
- hydromorphone
- hydroxybutyrate
- Disturbance in attention: 0% - 4%
- insulin detemir
- isomannide
- isosorbide-5-mononitrate
- ketorolac
- ketorolac tromethamine
- Cerebration impaired: postmarketing
- lacosamide
- levetiracetam
- Disturbance in attention: common
- lomefloxacin
- lorcaserin
- lormetazepam
- melatonin
- memantine
- metoprolol
- Cerebration impaired: uncommon
- mirtazapine
- Cerebration impaired: postmarketing
- modafinil
- Disturbance in attention: 1%
- montelukast
- Disturbance in attention: postmarketing
- nabilone
- nalmefene
- naltrexone
- naproxen
- Cerebration impaired: postmarketing
- nelarabine
- nicotine
- nifedipine
- nilotinib
- Disturbance in attention: uncommon
- oxcarbazepine
- Disturbance in attention: common
- Cerebration impaired: 2%
- paliperidone
- paroxetine
- Disturbance in attention: 0.3%
- Cerebration impaired: infrequent, common, frequent, 0.6% - 4.3%
- posaconazole
- pramipexole
- pregabalin
- Disturbance in attention: 1.4% - 5%
- Cerebration impaired
- progesterone
- quetiapine
- Disturbance in attention: 2%
- raltegravir
- Disturbance in attention
- Cerebration impaired
- ramipril
- retigabine
- Disturbance in attention: 6% - 7%
- ribavirin
- Disturbance in attention: common
- Cerebration impaired: common, very common, 5% - 21%
- rifampicin
- rifaximin
- rimantadine
- Cerebration impaired: 2.1%
- rimonabant
- Disturbance in attention: postmarketing
- risperidone
- Disturbance in attention: 0.9% - 4%
- Cerebration impaired: infrequent, 0% - 2%
- ritonavir
- rivastigmine
- Cerebration impaired: infrequent
- rizatriptan
- ropinirole
- Disturbance in attention: infrequent
- Cerebration impaired: infrequent, frequent, 2%
- rufinamide
- Disturbance in attention: 3%
- scopolamine
- Disturbance in attention: postmarketing
- sertraline
- Disturbance in attention: postmarketing
- Cerebration impaired: common
- sibutramine
- sitaxsentan
- sofosbuvir
- Disturbance in attention: common
- tapentadol
- Disturbance in attention: 1%
- tegaserod
- telithromycin
- temozolomide
- Cerebration impaired: common, 1% - 3%
- testosterone
- tiagabine
- Cerebration impaired: 6% - 14%
- Attention concentration difficulty
- topiramate
- Disturbance in attention: 2.6% - 11.9%
- Cerebration impaired: postmarketing, 0% - 15%
- Attention concentration difficulty: postmarketing
- tramadol
- Disturbance in attention: postmarketing, uncommon
- Cerebration impaired
- trazodone
- tropicamide
- trovafloxacin
- v 1784
- Cerebration impaired: postmarketing
- valproate
- varenicline
- Disturbance in attention: frequent
- vigabatrin
- Disturbance in attention: common, 0% - 9%
- Cerebration impaired
- zalcitabine
- zaleplon
- ziconotide
- ziprasidone
- Disturbance in attention: uncommon
- zolpidem
- Disturbance in attention: 2%
- Cerebration impaired
- zonisamide
- zuclopenthixol
|